Concepts (203)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Influenza, Human | 21 | 2025 | 699 | 3.430 |
Why?
|
| Rotavirus Vaccines | 14 | 2024 | 73 | 2.540 |
Why?
|
| Rotavirus Infections | 17 | 2024 | 357 | 2.370 |
Why?
|
| Influenza Vaccines | 11 | 2025 | 497 | 2.320 |
Why?
|
| Respiratory Tract Infections | 13 | 2025 | 294 | 2.170 |
Why?
|
| Hospitalization | 38 | 2025 | 1906 | 2.020 |
Why?
|
| Gastroenteritis | 14 | 2025 | 365 | 1.890 |
Why?
|
| Vaccination | 20 | 2024 | 1017 | 1.610 |
Why?
|
| Respiratory Syncytial Virus Infections | 9 | 2025 | 377 | 1.500 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 6 | 2025 | 188 | 1.450 |
Why?
|
| Infant | 58 | 2025 | 13240 | 1.100 |
Why?
|
| Rotavirus | 10 | 2024 | 502 | 1.100 |
Why?
|
| Immunization Programs | 5 | 2020 | 65 | 0.980 |
Why?
|
| Enterovirus Infections | 5 | 2025 | 49 | 0.940 |
Why?
|
| Respiratory Syncytial Virus, Human | 6 | 2025 | 233 | 0.920 |
Why?
|
| Child, Preschool | 51 | 2025 | 14884 | 0.900 |
Why?
|
| Child | 60 | 2025 | 25890 | 0.880 |
Why?
|
| United States | 43 | 2025 | 11763 | 0.730 |
Why?
|
| Case-Control Studies | 19 | 2025 | 3668 | 0.720 |
Why?
|
| Population Surveillance | 6 | 2025 | 419 | 0.700 |
Why?
|
| Prospective Studies | 22 | 2025 | 6601 | 0.680 |
Why?
|
| Antiviral Agents | 5 | 2025 | 824 | 0.650 |
Why?
|
| Reassortant Viruses | 3 | 2016 | 34 | 0.640 |
Why?
|
| Epidemiological Monitoring | 3 | 2018 | 63 | 0.630 |
Why?
|
| Metapneumovirus | 3 | 2025 | 52 | 0.620 |
Why?
|
| Emergency Service, Hospital | 9 | 2025 | 1156 | 0.600 |
Why?
|
| Enterovirus D, Human | 3 | 2025 | 11 | 0.580 |
Why?
|
| Arbovirus Infections | 1 | 2018 | 31 | 0.570 |
Why?
|
| Adolescent | 35 | 2025 | 20624 | 0.570 |
Why?
|
| Viruses | 3 | 2024 | 125 | 0.560 |
Why?
|
| Infant, Newborn | 26 | 2025 | 8623 | 0.560 |
Why?
|
| Influenza A Virus, H3N2 Subtype | 6 | 2025 | 123 | 0.540 |
Why?
|
| Humans | 86 | 2025 | 134156 | 0.540 |
Why?
|
| Fever | 2 | 2024 | 312 | 0.530 |
Why?
|
| Paramyxoviridae Infections | 3 | 2025 | 49 | 0.510 |
Why?
|
| Reminder Systems | 2 | 2016 | 65 | 0.500 |
Why?
|
| Seasons | 8 | 2025 | 334 | 0.490 |
Why?
|
| Immunization | 2 | 2021 | 315 | 0.490 |
Why?
|
| Respiratory Syncytial Virus Vaccines | 3 | 2025 | 71 | 0.480 |
Why?
|
| Adenovirus Infections, Human | 2 | 2025 | 57 | 0.460 |
Why?
|
| Adenoviruses, Human | 2 | 2025 | 99 | 0.460 |
Why?
|
| Female | 52 | 2025 | 71928 | 0.450 |
Why?
|
| Picornaviridae Infections | 2 | 2025 | 53 | 0.440 |
Why?
|
| Male | 50 | 2025 | 66127 | 0.430 |
Why?
|
| Acute Disease | 8 | 2025 | 1192 | 0.430 |
Why?
|
| Enterovirus | 2 | 2024 | 52 | 0.400 |
Why?
|
| Hospitals, Pediatric | 7 | 2024 | 791 | 0.390 |
Why?
|
| Texas | 12 | 2021 | 3716 | 0.390 |
Why?
|
| Vaccination Coverage | 2 | 2025 | 37 | 0.380 |
Why?
|
| Immunization Schedule | 5 | 2024 | 105 | 0.370 |
Why?
|
| Antibodies, Monoclonal, Humanized | 3 | 2025 | 556 | 0.370 |
Why?
|
| Antibodies, Viral | 1 | 2018 | 1211 | 0.370 |
Why?
|
| Information Systems | 1 | 2010 | 34 | 0.340 |
Why?
|
| Rhinovirus | 3 | 2025 | 64 | 0.330 |
Why?
|
| Genotype | 8 | 2025 | 2814 | 0.320 |
Why?
|
| Autism Spectrum Disorder | 3 | 2021 | 428 | 0.320 |
Why?
|
| Health Services Accessibility | 1 | 2015 | 649 | 0.310 |
Why?
|
| Vaccines, Synthetic | 4 | 2022 | 322 | 0.300 |
Why?
|
| Disease Outbreaks | 2 | 2021 | 330 | 0.290 |
Why?
|
| Vaccines, Attenuated | 8 | 2022 | 176 | 0.290 |
Why?
|
| Pregnancy Complications, Infectious | 2 | 2024 | 486 | 0.290 |
Why?
|
| Vaccines | 2 | 2023 | 380 | 0.270 |
Why?
|
| Systemic Inflammatory Response Syndrome | 3 | 2023 | 198 | 0.260 |
Why?
|
| Pediatrics | 1 | 2016 | 1215 | 0.250 |
Why?
|
| Mothers | 3 | 2024 | 370 | 0.250 |
Why?
|
| Severity of Illness Index | 5 | 2025 | 3114 | 0.250 |
Why?
|
| Feces | 8 | 2025 | 789 | 0.250 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 563 | 0.240 |
Why?
|
| Pandemics | 5 | 2024 | 1190 | 0.220 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2024 | 14 | 0.220 |
Why?
|
| Professionalism | 1 | 2024 | 51 | 0.210 |
Why?
|
| International Classification of Diseases | 1 | 2024 | 100 | 0.210 |
Why?
|
| Influenza B virus | 4 | 2025 | 100 | 0.210 |
Why?
|
| Parents | 5 | 2021 | 1071 | 0.200 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2024 | 151 | 0.200 |
Why?
|
| Connective Tissue Diseases | 1 | 2023 | 32 | 0.200 |
Why?
|
| Pregnancy | 6 | 2025 | 7570 | 0.190 |
Why?
|
| Prenatal Care | 1 | 2025 | 359 | 0.190 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 2022 | 35 | 0.190 |
Why?
|
| Turbinates | 1 | 2021 | 12 | 0.190 |
Why?
|
| Herpesvirus 1, Cercopithecine | 1 | 2021 | 2 | 0.190 |
Why?
|
| Caliciviridae Infections | 1 | 2025 | 358 | 0.180 |
Why?
|
| RNA, Viral | 2 | 2021 | 563 | 0.180 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2022 | 179 | 0.180 |
Why?
|
| Norovirus | 1 | 2025 | 347 | 0.180 |
Why?
|
| Public Health Surveillance | 1 | 2020 | 45 | 0.170 |
Why?
|
| Mobile Health Units | 1 | 2020 | 25 | 0.170 |
Why?
|
| Virus Diseases | 1 | 2022 | 290 | 0.160 |
Why?
|
| Outpatients | 1 | 2021 | 276 | 0.160 |
Why?
|
| Immunogenicity, Vaccine | 1 | 2020 | 114 | 0.160 |
Why?
|
| Family Health | 1 | 2020 | 268 | 0.160 |
Why?
|
| Diphtheria-Tetanus-Pertussis Vaccine | 1 | 2019 | 16 | 0.150 |
Why?
|
| Cross-Sectional Studies | 4 | 2025 | 3754 | 0.150 |
Why?
|
| Communicable Diseases, Imported | 1 | 2018 | 6 | 0.150 |
Why?
|
| Antigens, Viral | 3 | 2024 | 441 | 0.150 |
Why?
|
| Family Characteristics | 3 | 2025 | 91 | 0.150 |
Why?
|
| Bites and Stings | 1 | 2018 | 27 | 0.150 |
Why?
|
| Chikungunya Fever | 1 | 2018 | 30 | 0.140 |
Why?
|
| Genetic Variation | 1 | 2025 | 1631 | 0.140 |
Why?
|
| Lung Diseases | 1 | 2021 | 404 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2021 | 905 | 0.140 |
Why?
|
| Cost of Illness | 3 | 2025 | 277 | 0.140 |
Why?
|
| Travel | 1 | 2018 | 125 | 0.130 |
Why?
|
| Betacoronavirus | 1 | 2020 | 306 | 0.130 |
Why?
|
| Dengue | 1 | 2018 | 122 | 0.130 |
Why?
|
| Autistic Disorder | 1 | 2020 | 374 | 0.130 |
Why?
|
| West Nile Fever | 1 | 2018 | 139 | 0.130 |
Why?
|
| Coinfection | 1 | 2018 | 184 | 0.130 |
Why?
|
| Developmental Disabilities | 1 | 2021 | 742 | 0.120 |
Why?
|
| Fucosyltransferases | 1 | 2015 | 30 | 0.120 |
Why?
|
| Electronic Health Records | 1 | 2023 | 797 | 0.120 |
Why?
|
| Genome, Viral | 1 | 2016 | 185 | 0.120 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 385 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 396 | 0.120 |
Why?
|
| Database Management Systems | 1 | 2014 | 32 | 0.110 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2016 | 193 | 0.110 |
Why?
|
| Statistics as Topic | 1 | 2015 | 261 | 0.110 |
Why?
|
| Product Surveillance, Postmarketing | 2 | 2010 | 32 | 0.110 |
Why?
|
| Phylogeny | 1 | 2016 | 785 | 0.100 |
Why?
|
| Forecasting | 1 | 2014 | 377 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2024 | 2915 | 0.100 |
Why?
|
| Patient Acuity | 2 | 2022 | 67 | 0.090 |
Why?
|
| Child, Hospitalized | 2 | 2022 | 76 | 0.090 |
Why?
|
| Hospital Information Systems | 1 | 2010 | 46 | 0.080 |
Why?
|
| Serum | 1 | 2010 | 46 | 0.080 |
Why?
|
| Adult | 4 | 2025 | 31945 | 0.080 |
Why?
|
| Risk Factors | 4 | 2025 | 11182 | 0.080 |
Why?
|
| Time Factors | 3 | 2025 | 6610 | 0.070 |
Why?
|
| Young Adult | 2 | 2025 | 9944 | 0.070 |
Why?
|
| Prevalence | 2 | 2025 | 2684 | 0.070 |
Why?
|
| Informed Consent | 1 | 2010 | 345 | 0.070 |
Why?
|
| Absenteeism | 1 | 2024 | 19 | 0.060 |
Why?
|
| Vaccination Refusal | 1 | 2024 | 19 | 0.060 |
Why?
|
| Asymptomatic Infections | 1 | 2024 | 38 | 0.060 |
Why?
|
| Vomiting | 1 | 2025 | 110 | 0.060 |
Why?
|
| Cohort Studies | 2 | 2024 | 5222 | 0.050 |
Why?
|
| RNA, Messenger, Stored | 1 | 2023 | 7 | 0.050 |
Why?
|
| Sensitivity and Specificity | 2 | 2024 | 2172 | 0.050 |
Why?
|
| Drug Utilization | 1 | 2024 | 170 | 0.050 |
Why?
|
| Crowding | 1 | 2023 | 11 | 0.050 |
Why?
|
| Diarrhea | 1 | 2025 | 343 | 0.050 |
Why?
|
| Hospital Costs | 1 | 2024 | 187 | 0.050 |
Why?
|
| Multiplex Polymerase Chain Reaction | 1 | 2022 | 33 | 0.050 |
Why?
|
| Coronavirus | 1 | 2022 | 27 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2015 | 867 | 0.050 |
Why?
|
| Oseltamivir | 1 | 2021 | 19 | 0.050 |
Why?
|
| Antibodies, Bacterial | 1 | 2024 | 407 | 0.050 |
Why?
|
| Life Support Care | 1 | 2022 | 47 | 0.050 |
Why?
|
| Immunization, Passive | 1 | 2022 | 129 | 0.050 |
Why?
|
| Immunization, Secondary | 1 | 2022 | 113 | 0.040 |
Why?
|
| Health Care Costs | 1 | 2024 | 408 | 0.040 |
Why?
|
| Minority Groups | 1 | 2022 | 256 | 0.040 |
Why?
|
| Transients and Migrants | 1 | 2020 | 24 | 0.040 |
Why?
|
| Adenoviridae | 1 | 2022 | 609 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 152 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 582 | 0.040 |
Why?
|
| Hospitals | 1 | 2022 | 437 | 0.040 |
Why?
|
| Urban Population | 2 | 2010 | 243 | 0.040 |
Why?
|
| Age Factors | 2 | 2019 | 2998 | 0.040 |
Why?
|
| Interviews as Topic | 1 | 2020 | 421 | 0.040 |
Why?
|
| Medically Uninsured | 1 | 2019 | 76 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2022 | 1493 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2022 | 538 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 1332 | 0.040 |
Why?
|
| Critical Illness | 1 | 2022 | 629 | 0.030 |
Why?
|
| Asthma | 1 | 2025 | 810 | 0.030 |
Why?
|
| Poverty | 1 | 2020 | 438 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2022 | 1072 | 0.030 |
Why?
|
| Poliovirus Vaccines | 1 | 2016 | 14 | 0.030 |
Why?
|
| Chickenpox Vaccine | 1 | 2016 | 14 | 0.030 |
Why?
|
| Haemophilus Vaccines | 1 | 2016 | 32 | 0.030 |
Why?
|
| Measles-Mumps-Rubella Vaccine | 1 | 2016 | 14 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 1625 | 0.030 |
Why?
|
| Hepatitis B Vaccines | 1 | 2016 | 45 | 0.030 |
Why?
|
| Diphtheria-Tetanus-acellular Pertussis Vaccines | 1 | 2016 | 35 | 0.030 |
Why?
|
| Inpatients | 1 | 2019 | 547 | 0.030 |
Why?
|
| Canada | 1 | 2016 | 346 | 0.030 |
Why?
|
| Cattle | 1 | 2016 | 589 | 0.030 |
Why?
|
| Software Design | 1 | 2014 | 24 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2024 | 3743 | 0.030 |
Why?
|
| Saliva | 1 | 2015 | 133 | 0.030 |
Why?
|
| Models, Organizational | 1 | 2014 | 44 | 0.030 |
Why?
|
| Premature Birth | 1 | 2019 | 418 | 0.030 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2014 | 172 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2014 | 179 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2021 | 5477 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 2015 | 414 | 0.020 |
Why?
|
| Presumed Consent | 1 | 2010 | 4 | 0.020 |
Why?
|
| Hospitals, Maternity | 1 | 2010 | 8 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 964 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 3980 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2010 | 258 | 0.020 |
Why?
|
| Costs and Cost Analysis | 1 | 2010 | 165 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2013 | 414 | 0.020 |
Why?
|
| Age Distribution | 1 | 2010 | 444 | 0.020 |
Why?
|
| Aged | 1 | 2025 | 21775 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 2301 | 0.010 |
Why?
|
| Middle Aged | 1 | 2025 | 29399 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2015 | 3506 | 0.010 |
Why?
|
| Registries | 1 | 2010 | 1578 | 0.010 |
Why?
|
| Mutation | 1 | 2015 | 6338 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2015 | 13074 | 0.010 |
Why?
|
| Animals | 1 | 2016 | 36557 | 0.010 |
Why?
|